thenoyltrifluoroacetone has been researched along with Alloxan Diabetes in 1 studies
Thenoyltrifluoroacetone: Chelating agent and inhibitor of cellular respiration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiritoshi, S | 1 |
| Nishikawa, T | 1 |
| Sonoda, K | 1 |
| Kukidome, D | 1 |
| Senokuchi, T | 1 |
| Matsuo, T | 1 |
| Matsumura, T | 1 |
| Tokunaga, H | 1 |
| Brownlee, M | 1 |
| Araki, E | 1 |
1 other study available for thenoyltrifluoroacetone and Alloxan Diabetes
| Article | Year |
|---|---|
Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy.
Topics: Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carrier Proteins; Cells, Cultured; Chelating Age | 2003 |